Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer (Pyrotinib)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03933982
Recruitment Status : Recruiting
First Posted : May 1, 2019
Last Update Posted : May 29, 2019
Information provided by (Responsible Party):
Peng Yuan, Chinese Academy of Medical Sciences

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 22, 2021
Estimated Study Completion Date : June 22, 2022